VRXA Veraxa Biotech AG - Post de-SPAC

VRXA financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 2079109 SIC: 2834 (Pharmaceutical Preparations) Data checked: Oct 21, 2026

Filer Category

<br>Emerging growth company

Entity Type

Other

Industry (SIC)

2834 Pharmaceutical Preparations

Incorporated

Fiscal Year End

December (1231)

Phone

41443858450

EIN

000000000

Headquarters

ZURICH, 8001

Former Names: Veraxa Biotech Holding AG (2025–2026)

The latest cached filing data contained no eligible financial facts. Any historical values shown below have been retained.

📊

No supported financial periods are available for this company.